Rina Falb
Impact in
-
- Multiple Sclerosis Research Studies
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 1
-
- Multiple Sclerosis Research Studies 3
- Co-authors
- Anat Achiron (11 shared papers)Michael Gurevich (11 shared papers)Sapir Dreyer-Alster (8 shared papers)Mark Dolev (8 shared papers)David Magalashvili (8 shared papers)Shay Menascu (7 shared papers)Shlomo Flechter (5 shared papers)Mathilda Mandel (8 shared papers)
- Journals
- Therapeutic Advances in Neurological Disorders (2 papers)Clinical Microbiology and Infection (1 paper)Journal of the Neurological Sciences (1 paper)PLoS ONE (1 paper)Multiple Sclerosis and Related Disorders (1 paper)
- Partner nations
- Israel
In The Last Decade
Rina Falb
11 papers receiving 490 citations
Rina Falb's Hit Papers
Peers
Comparison fields: 5 of 40
- Pathology and Forensic Medicine 240
- Infectious Diseases 248
- Neurology 98
- Immunology 62
- Health 20
Countries citing papers authored by Rina Falb
This map shows the geographic impact of Rina Falb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Falb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Falb more than expected).
Fields of papers citing papers by Rina Falb
This network shows the impact of papers produced by Rina Falb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Falb. The network helps show where Rina Falb may publish in the future.
Co-authors
The 14 scholars most cited alongside Rina Falb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies Hit paper breakdown → | 2021 | 236 |
| 2 | 2021 | 147 | |
| 3 | 2022 | 40 | |
| 4 | 2022 | 27 | |
| 5 | 2021 | 26 | |
| 6 | 2015 | 8 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2021 | 2 | |
| 11 | 2024 | 1 |
About Rina Falb
Rina Falb is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Neurology, Animal Science and Zoology and Neurology, having authored 11 papers that have together received 498 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Multiple Sclerosis Research Studies (3 papers), Neurogenesis and neuroplasticity mechanisms (1 paper), Long-Term Effects of COVID-19 (1 paper), COVID-19 Clinical Research Studies (1 paper), Immunotherapy and Immune Responses (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Animal Virus Infections Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (240 citations), Infectious Diseases (248 citations), Neurology (98 citations), Immunology (62 citations) and Health (20 citations). Rina Falb has collaborated with scholars based in Israel. Frequent co-authors include Anat Achiron, Michael Gurevich, Sapir Dreyer-Alster, Mark Dolev, David Magalashvili, Shay Menascu, Shlomo Flechter, Mathilda Mandel, Polina Sonis and Gil Harari. Their work appears in journals such as Therapeutic Advances in Neurological Disorders, Clinical Microbiology and Infection, Journal of the Neurological Sciences, PLoS ONE and Multiple Sclerosis and Related Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.